This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 May 1;353(9163):1524; author reply 1525.

doi: 10.1016/S0140-6736(05)75133-3.

Immunotherapy for colon cancer

E Blot, O Delastre, H Levesque

PMID: 10232339
DOI: 10.1016/S0140-6736(05)75133-3

Comment

Immunotherapy for colon cancer

E Blot et al. Lancet. 1999.

. 1999 May 1;353(9163):1524; author reply 1525.

doi: 10.1016/S0140-6736(05)75133-3.

Authors

E Blot, O Delastre, H Levesque

PMID: 10232339
DOI: 10.1016/S0140-6736(05)75133-3

No abstract available

PubMed Disclaimer

Comment on

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG Jr, Pinedo HM. Vermorken JB, et al. Lancet. 1999 Jan 30;353(9150):345-50. doi: 10.1016/S0140-6736(98)07186-4. Lancet. 1999. PMID: 9950438 Clinical Trial.
Colorectal cancer.
Midgley R, Kerr D. Midgley R, et al. Lancet. 1999 Jan 30;353(9150):391-9. doi: 10.1016/S0140-6736(98)07127-X. Lancet. 1999. PMID: 9950460 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.